Question 1

What is FOMAT?

Accepted Answer

FOMAT (formerly FOMAT Medical Research) is an Embedded Research Organization headquartered in Oxnard, California, with a growing presence across the United States. With over a decade of experience, FOMAT conducts Phase I, II, and III clinical trials across multiple therapeutic areas, with a mission focused on diversifying access to clinical research and bringing healthcare innovations to underrepresented populations. FOMAT works with sponsors, CROs, and principal investigators nationwide to deliver high-quality clinical data under Good Clinical Practice standards.

Question 2

What is an Embedded Research Organization (ERO)?

Accepted Answer

An Embedded Research Organization (ERO) integrates clinical research directly into existing healthcare settings — such as physician practices, clinics, and health systems — rather than operating as a standalone research facility. FOMAT is built around this model, placing dedicated research teams at the point of care, where patients are already receiving treatment. Through EHR-based prescreening, multilingual community outreach, and paperless enrollment, FOMAT's embedded approach improves patient recruitment, reduces barriers to participation, and delivers more consistent trial execution for sponsors and CROs across the United States.

Question 3

What services does FOMAT offer for Sponsors and CROs?

Accepted Answer

FOMAT offers a comprehensive range of clinical trial services for sponsors and CROs, including a dedicated Phase I Unit for early-phase studies, and full lifecycle Phase II–III execution across a broad range of therapeutic areas. Our services also include quality control and GCP compliance oversight, and patient recruitment excellence — all delivered through an operational model built for consistent, reliable execution from site activation through study closeout. If you would like to partner with FOMAT for your next clinical trial, contact our Business Development team at (805) 483-1185 or bd@fomatmedical.com.

Question 4

Where is FOMAT located?

Accepted Answer

FOMAT is headquartered in Oxnard, California at 300 S A Street, Suite 201. In addition to its headquarters, FOMAT operates multiple hubs throughout the United States, bringing embedded clinical research closer to patients and healthcare providers across the country. For inquiries, contact FOMAT at (805) 483-1185 or visit fomatmedical.com/contact-fomat.

Question 5

What therapeutic areas does FOMAT have experience in for clinical research?

Accepted Answer

FOMAT has extensive clinical research experience across a broad range of therapeutic areas, including Allergy and Immunology, Cardiology, Dermatology, Family and Internal Medicine, Gastroenterology, Infectious Diseases and Vaccines, Metabolics and Endocrinology, Nephrology, Ophthalmology and Retina, Oncology, Pediatrics, Rheumatology, Urology, and Wound Care. This diverse portfolio allows FOMAT to support sponsors and CROs across multiple indications within its embedded research network throughout the United States.

Question 6

What awards and milestones has FOMAT achieved?

Accepted Answer

FOMAT has earned recognition across the clinical research industry for its commitment to patient centricity, diversity, and innovation. Key awards and recognitions include: 2025 Top Nominee for Best Clinical Trial Company by the ViE Awards, which recognizes outstanding performance in the vaccine and clinical trial industry; 2024 Winner of the Excellence in Patient Centricity Award by SCRS (Society for Clinical Research Sites), which honors research sites that demonstrate exceptional commitment to the patient experience; 2024 Top Nominee as Proud Member of HyperCore by the ViE Awards, recognizing elite clinical trial sites with demonstrated excellence in trial execution and diversity; 2022 Top Nominee for the Site Excellence in Patient Inclusion Award, which highlights organizations leading efforts to include underrepresented populations in clinical research; and 2020 Innovative Business of the Year by the Oxnard Chamber of Commerce, recognizing FOMAT's impact as a healthcare innovator in the local community. These recognitions reflect FOMAT's ongoing mission to put patients first, advance diversity in clinical trials, and continuously raise the standard of care for every participant in the research process.

Question 7

What is a clinical trial and is it safe to participate?

Accepted Answer

A clinical trial is a research study conducted with human volunteers to evaluate the safety and effectiveness of new medical treatments, medications, or devices. At FOMAT, all clinical trials follow strict ethical standards and Good Clinical Practice (GCP) guidelines to protect every participant. Trials are reviewed and approved by independent ethics committees before any patient is enrolled, and participants are fully informed of any risks before agreeing to take part. Safety and transparency are at the core of everything FOMAT does.

Question 8

How can I find and join a clinical trial at FOMAT?

Accepted Answer

Finding and joining a clinical trial at FOMAT is straightforward. You can browse currently open studies at fomatmedical.com/patient-active-studies. Once you find a study that may be a fit, our team of specialists will review your profile to determine which studies are the best match for you. To get started, contact our Trials Information team at (805) 465-3574 or volunteers@fomatmedical.com — we are here to guide you through every step of the process.

Question 9

Do I get paid for participating in a clinical trial at FOMAT?

Accepted Answer

Yes, participants are compensated for their time and involvement in clinical trials at FOMAT. The compensation amount depends on the specific study and the time required for participation. If you have any questions about compensation for a specific study, do not hesitate to contact our team at (805) 465-3574 or volunteers@fomatmedical.com.

Question 10

Do I need health insurance to participate in a FOMAT clinical trial?

Accepted Answer

No, you do not need health insurance to participate in a clinical trial at FOMAT. Study-related care and procedures are provided as part of the trial at no cost to participants.

Question 11

Are FOMAT clinical trials available in Spanish?

Accepted Answer

Yes, absolutely. FOMAT has bilingual teams ready to assist you and provide all the information you need in both English and Spanish, from your first inquiry through your last visit. No language barrier should stand between you and access to innovative healthcare. Contact us at (805) 465-3574 or volunteers@fomatmedical.com.

Question 12

How can a physician or medical practice join the FOMAT investigator network?

Accepted Answer

Physicians, medical groups, and clinical sites interested in bringing clinical research to their practice can join the FOMAT investigator network across the United States. FOMAT's embedded model integrates research staff and workflows directly into your existing practice, so your team is not managing everything alone. To learn more about the benefits of joining one of the leading clinical research site networks in the country, visit fomatmedical.com/physician-investigator-network or contact our Business Development team at bd@fomatmedical.com.

Question 13

What support does FOMAT provide to physician investigators?

Accepted Answer

FOMAT provides comprehensive support to physician investigators through its embedded research model, including: dedicated research staff aligned to your practice flow; feasibility support to confirm each study fits your patient population and daily clinic workflow; coordination of activation tasks and study start-up workflows; smarter recruitment pathways to identify eligible patients and manage follow-up; retention support to keep participants engaged and on schedule across visits; quality and compliance oversight with consistent standards across all sites; and an additional source of revenue for your practice based on study activities. To learn more, visit fomatmedical.com/physician-investigator-network.

3rd Doctor Dies from Ebola

Liberia Gets ZMapp

Genetics to Test Ebola Vaccine

Debate Continues Over Experimental Ebola Drugs

Ebola Outbreak an International Public Health Emergency Declared by WHO

New Brain Protein Tied to Alzheimer’s Disease

Study Says 99% of Alzheimer’s Drug Trials Fail

Insulin Pump Outperformed by ‘Bionic Pancreas’

Newly arrived virus in Caribbean gains strength

Subscribe for latest updates & insights

Contacts

Patients

Sponsors

About Us